NIH-funded research R01 grant

Personalized digital models for acute myeloid leukemia

Official title: Prototype System for AML Digital Twins

Funded at Institute for Systems Biology · NIH-11492233 · Data updated 2026-11-12

This project creates a computer model of a person's AML from their blood and bone marrow data so doctors and patients can explore which treatments might work best.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionInstitute for Systems Biology
NIH-funded
Lab location1 site (Seattle, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2026
Award (this year)$72,373
NIH project number3R01CA270210-04S1
Project IDNIH-11492233 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older with acute myeloid leukemia who can provide clinical data plus blood and bone marrow specimens, including patients with relapsed or refractory disease.

Less likely to help

People without AML, those unable or unwilling to give required samples, or patients needing immediate emergency therapy are unlikely to benefit from this prototype.

What this research studies

If I had AML, researchers would build a computer 'digital twin' of my leukemia using my clinical records, blood tests, and a bone marrow sample. The model combines clinical and molecular data to simulate how my disease might respond to different drugs. Doctors could use an interactive tool with me to compare predicted outcomes of treatment options without trying them on my body first. The team at the Institute for Systems Biology is creating a prototype system that would require sharing samples and health data with the research group.

Why it matters

Potential benefit: Could help tailor treatment choices by predicting which therapies are most likely to work for an individual patient's AML.

How similar studies have gone: Digital twin methods have shown early promise in other medical areas, but applying them to AML is largely new and still experimental.

Where this research is happening

  • Institute for Systems Biology
    Seattle, United States
    Active

Researchers

  • Principal investigator: Thorsson, Vesteinn — Institute for Systems Biology
  • Study coordinator: Thorsson, Vesteinn

Related research

Other NIH-funded projects on the same topics.

  • Digital twin to personalize acute myeloid leukemia treatment

    This project builds a virtual copy of an adult's AML using their blood and bone marrow data so doctors can try out treatment options on the model before giving them to the patient.

    NIH research Institute for Systems Biology · Seattle, United States · NIH-11492240

  • Understanding how Bacteroides fragilis changes affect phage therapy

    Researchers will study how a common gut bacterium changes its surface and defense features to evade phages, with the goal of improving phage-based treatments for infections and related diseases.

    NIH research Institute for Systems Biology · Seattle, United States · NIH-11450793

  • AI-powered cancer data hub to map tumor risk and treatment responses

    A cancer-focused project will build an AI-driven data platform that combines genomic, transcriptomic, proteomic, and spatial data to better understand cancer risk and how tumors respond to treatment.

    NIH research Institute for Systems Biology · Seattle, United States · NIH-11450436

  • Understanding why some bacteria hide inside cells during infection

    A study will look at how a tiny number of Salmonella bacteria inside human cells survive antibiotic treatment by changing both their own genes and the host cell’s gene activity.

    NIH research Institute for Systems Biology · Seattle, United States · NIH-11440671

  • Tissue imaging and spatial profiling resources for tumor studies

    A core research resource helps researchers study tumor tissues with advanced imaging and multi-omic profiling to understand their biology.

    NIH research Institute for Systems Biology · Seattle, United States · NIH-11415811

  • Core 1: Mouse Model and Tissue Biobank Core

    A research core helps study how immune therapies interact with melanoma treatments using mouse models and human tissue samples, aiming to improve outcomes for kids and others who might benefit in the future.

    NIH research Institute for Systems Biology · Seattle, United States · NIH-11415810

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.